Taiwan FDA registration 0b51f73db1dbcb1af0ec225b53ce6c1d
“Cryotech”Cell-freezing apparatus and reagents for in vitro diagnostic use (Non-Sterile)
TW: “磊柏”體外診斷用的細胞冷凍設備及反應劑 (未滅菌)
Taiwan·Risk Class 1·MD·REPROLIFE INC.·Registered Dec 04, 2020 – Dec 04, 2025ExpiredRegistration details
- Analysis ID
- 0b51f73db1dbcb1af0ec225b53ce6c1d
- License Form
- Ministry of Health Medical Device Import No. 022158
- Customs Code
- DHA09402215804
Company information
- Manufacturer
- REPROLIFE INC.
- Manufacturer Country
- Japan
- Authorized Representative
- LabIVF Taiwan International Co., Ltd
Product details
- Intended Use
- Limited to the first level identification range of cell cryogenic equipment and reactants (B.9225) for in vitro diagnosis of medical device management methods.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B9225 Cell cryogenic equipment and reactants for in vitro diagnostics
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Dec 04, 2020
- Expiry Date
- Dec 04, 2025
About this record
Access comprehensive regulatory information for “Cryotech”Cell-freezing apparatus and reagents for in vitro diagnostic use (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 0b51f73db1dbcb1af0ec225b53ce6c1d and manufactured by REPROLIFE INC.. The authorized representative in Taiwan is LabIVF Taiwan International Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices